Skip to main content
Back
Watch Compare

ALX ONCOLOGY HOLDINGS INC

Data quality: 83%
ALXO
Nasdaq Manufacturing Chemicals
$1.70
$0.00 (0.00%)
Mkt Cap: 223.73 M
Price
$1.70
Mkt Cap
223.73 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Debt/Equity of 0.24 — conservative balance sheet
Negative free cash flow of -84.35 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-186.23%
Below sector avg (-53.34%)
ROIC-125.01%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
0.24
Below sector avg (0.31)
Current Ratio2.40
Interest Coverage-64.93

Valuation

PE (TTM)
-2.20
Below sector avg (-1.47)
P/B Ratio4.99
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -2.2 -1.5
P/B 5.0 1.6
ROE % -186.2 -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E 0.2 0.3

Analyst Price Target

5 analysts
Buy
Current
$1.70
+170.6%
Target
$4.60
$4.00
$4.00
$6.00
Forecast
Forward P/E -2.77
Forward EPS -$0.61
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.61
-$0.69 – -$0.54
 0.0 2
FY2026 -$0.65
-$0.65 – -$0.65
 0.0 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.32 -$0.37 -15.5%
Q32025 -$0.37 -$0.41 -10.1%
Q22025 -$0.31 -$0.44 -43.1%
Q12025 -$0.31 -$0.48 -54.5%

ETFs Holding This Stock

BRUSX BRUSX
0.02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -101.70 M
ROE -186.23% ROA -114.24%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -84.35 M
ROIC -125.01% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.24 Current Ratio 2.40
Interest Coverage -64.93 Asset Turnover N/A
Working Capital 38.79 M Tangible Book Value 44.80 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.20 Forward P/E N/A
P/B Ratio 4.99 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -37.70%
Market Cap 223.73 M Enterprise Value 210.89 M
Per Share
EPS (Diluted TTM) -1.90 Revenue / Share N/A
FCF / Share -0.64 OCF / Share -0.64
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 82.95%
SBC-Adj. FCF -101.18 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 0.0 1.18 M
Net Income -101.70 M -134.85 M -160.81 M -123.48 M -83.46 M
EPS (Diluted) -1.90 -2.58 -3.74 -3.03 —
Gross Profit — — — — —
Operating Income -104.02 M -142.47 M -170.28 M -127.44 M -83.56 M
EBITDA — — — — —
R&D Expenses 77.00 M 116.37 M 141.80 M 98.40 M 60.17 M
SG&A Expenses — — — — —
D&A 706,000.0 872,000.0 836,000.0 342,000.0 51,000.0
Interest Expense 1.60 M 1.73 M 1.57 M — —
Income Tax 0.0 64,000.0 64,000.0 64,000.0 -21,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 59.05 M 147.78 M 242.55 M 306.49 M 380.18 M
Total Liabilities 33.07 M 34.16 M 52.84 M 43.03 M 17.13 M
Shareholders' Equity 25.98 M 113.62 M 189.71 M 263.46 M 363.05 M
Total Debt 10.17 M 10.60 M 10.60 M 10.60 M —
Cash & Equivalents 16.37 M 17.57 M 22.41 M 48.82 M 363.67 M
Current Assets 50.73 M 134.35 M 188.66 M 270.97 M 367.02 M
Current Liabilities 24.55 M 18.50 M 36.00 M 28.33 M 15.30 M